ESR1 and breast cancer: Conversely, some authors suggest that HHL should be avoided in the presence of BC or other estrogen-dependent cancers, as phytoestrogens (especially 8-prenylnaringenin and 6-prenylnaringenin) act as agonists on both ER-α and ER-β [80,81].